MISSION VIEJO, Calif.--(BUSINESS WIRE)--CynergisTek, Inc. (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity and information management, today announced financial results for the first quarter that ended March 31, 2018.
Financial highlights for the first quarter 2018 include:
- Revenues for the first quarter were $16.4 million, a decrease of 10 percent from $18.3 million in the first quarter of 2017.
- Gross margins for the first quarter 2018 were 25 percent compared to 25 percent for the same period in 2017.
- GAAP net loss for the first quarter was $(0.7) million, or $(0.07) per basic and diluted share compared to net income of $0.01 million, or $0.00 per basic and diluted share in the same period of 2017.
- Non-GAAP adjusted EBITDA and Non-GAAP adjusted earnings exclude non-recurring charges related to our recent debt refinancing and the departure of a senior executive, totaling $0.7 million.
- Non-GAAP adjusted EBITDA was $0.9 million in the first quarter of 2018, compared to $1.1 million for the same period in 2017.
- Non-GAAP adjusted earnings per share for the first quarter 2018 was $0.06 per basic and $0.05 per diluted share, compared to $0.07 per basic and diluted share for the same period of 2017.
Recent operational highlights include:
- Announced the first full-service managed print service contract that includes an integrated print security assessment component.
- Expanded managed services cross-selling efforts by successfully adding a three-year CAPP contract to our newest managed print service client.
- Maintained a 95 percent client renewal rate for the quarter.
- Grew the pipeline for both new and existing managed services, particularly Patient Privacy Monitoring, Incident Response, and Biomedical Device Security.
“In Q1, our focus was to strengthen relationships with our clients, grow the managed services pipeline, and develop and improve our services offerings to better meet existing and emergent client needs,” said Mac McMillan, President and CEO of CynergisTek. “I am pleased with the progression we made in all three of those areas. This focus reiterates that we are here to help our clients build cybersecurity and privacy programs during a time where healthcare continues to experience an increase of cyber attacks.”
Financial results for the three months ended March 31, 2018
Revenue decreased by approximately $1.9 million to $16.4 million for the three months ended March 31, 2018, as compared to the same period in 2017. This decrease is a result of approximately $2.5 million less in managed service revenues due to approximately $3.8 million in non-renewals of long-term contracts, partially offset by approximately $1.3 million in additional revenues from the expansion of existing customers and contracts from new customers; approximately $0.8 million in additional revenues from consulting and professional services provided to new and existing customers; and approximately $0.2 million less in equipment revenues in 2018.
Cost of revenue was $12.2 million for the three months ended March 31, 2018, as compared to $13.7 million for the same period in 2017. We incurred approximately $0.2 million less in staffing costs, and approximately $1.0 million less in supplies and third-party services, largely as a result of the net reduction in managed services contracts. Equipment costs decreased by approximately $0.2 million in 2018.
Gross margin remained at 25 percent of revenue for the three months ended March 31, 2018 as compared to 2017. We were successful in adjusting our staffing to be reflective of our current service activity. Over the second half of 2018 and into next year, we expect gross margins to improve as we look to increase growth in our cybersecurity services.
Sales and marketing expenses were $1.5 million for the three months ended March 31, 2018, as compared to $1.4 million for the same period in 2017. Our tradeshow and forum related marketing expenses were approximately $0.1 million more in 2018 as we actively pursue new business.
General and administrative expenses increased to $2.6 million for the three months ended March 31, 2018, as compared to $2.2 million for the three months ended March 31, 2017. The increase is attributed to approximately $0.6 million in severance paid to a departed executive offset by a decrease in professional fees and travel costs in 2018, where 2017 included higher costs in connection with the acquisition and integration of CTEK Security.
Income tax benefit for the three months ended March 31, 2018 was $0.2 million compared to income tax expense of $0.01 million for the same period in 2017. The 2018 benefit is based on an estimated annual income tax expense rate we anticipate for the year as we expect to be in a tax expense position by year-end. The 2017 expense was based on similar terms and was influenced by state minimum tax charges.
Net loss was $(0.7) million for the three months ended March 31, 2018, or $(0.07) per basic and diluted share, compared to net income of $0.01 million, or $0.00 per basic and diluted share in the same period of 2017.
The reconciliation of GAAP to non-GAAP information can be found in the tables at the end of this release and provide the details of the Company’s non-GAAP disclosures and the reconciliation of non-GAAP information.
Non-GAAP adjusted EBITDA, when adding back stock-based compensation, non-recurring charges related to our recent debt refinancing and the departure of a senior executive was $0.9 million in the first quarter of 2018, compared to $1.1 million for the same period in 2017.
Non-GAAP adjusted earnings for the first quarter of 2018 was $0.5 million, or $0.06 per basic and $0.05 per diluted share after adjusting for non-cash income tax benefit, non-recurring charges related to our recent debt refinancing and the departure of a senior executive, amortization of intangibles, stock-based compensation and depreciation, with all adjustments totaling $1.2 million, compared to $0.6 million or $0.07 per basic and diluted share after adjusting for non-cash income tax expense, amortization of intangibles, stock-based compensation and depreciation, with all adjustments totaling $0.6 million, for the same period of 2017.
|
CYNERGISTEK, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||||
|
March 31, 2018 |
December 31, 2017 | |||||||||
| ASSETS | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 3,409,293 | $ | 4,252,060 | ||||||
| Accounts receivable, net | 10,577,287 | 13,264,323 | ||||||||
| Prepaid and other current assets | 1,590,277 | 557,426 | ||||||||
| Supplies | 1,085,762 | 1,156,006 | ||||||||
| Total current assets | 16,662,619 | 19,229,815 | ||||||||
| Property and equipment, net | 766,476 | 831,784 | ||||||||
| Deposits | 87,778 | 87,376 | ||||||||
| Deferred income taxes | 3,350,310 | 3,120,310 | ||||||||
| Intangible assets, net | 10,448,190 | 10,900,924 | ||||||||
| Goodwill | 18,525,206 | 18,525,206 | ||||||||
| Total assets | $ | 49,840,579 | $ | 52,695,415 | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable and accrued expenses | $ | 5,171,719 | $ | 9,631,634 | ||||||
| Accrued compensation and benefits | 2,715,474 | 3,711,551 | ||||||||
| Deferred revenue | 1,035,470 | 1,425,821 | ||||||||
| Note payable | 343,750 | - | ||||||||
| Current portion of long-term liabilities | 3,130,230 | 5,494,837 | ||||||||
| Total current liabilities | 12,396,643 | 20,263,843 | ||||||||
| Long-term liabilities: | ||||||||||
| Term loan, less current portion | 14,676,081 | 9,438,333 | ||||||||
| Promissory notes to related parties, less current portion | 5,437,500 | 6,000,000 | ||||||||
| Capital lease obligations, less current portion | 124,392 | 147,861 | ||||||||
| Total long-term liabilities | 20,237,973 | 15,586,194 | ||||||||
| Commitments and contingencies | ||||||||||
| Stockholders’ equity: | ||||||||||
| Common stock, par value at $0.001, 33,333,333 shares authorized, 9,592,547 shares issued and outstanding at March 31, 2018 and 9,576,028 shares issued and outstanding at December 31, 2017 | 9,593 | 9,576 | ||||||||
| Additional paid-in capital | 31,344,607 | 31,156,362 | ||||||||
| Accumulated deficit | (14,148,237 | ) | (14,320,560 | ) | ||||||
| Total stockholders’ equity | 17,205,963 | 16,845,378 | ||||||||
| Total liabilities and stockholders’ equity | $ | 49,840,579 | $ | 52,695,415 | ||||||
|
CYNERGISTEK, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
||||||||||
| Three Months Ended March 31, | ||||||||||
| 2018 | 2017 | |||||||||
| Net revenues | $ | 16,383,317 | $ | 18,254,689 | ||||||
| Cost of revenues | 12,237,865 | 13,667,541 | ||||||||
| Gross profit | 4,145,452 | 4,587,148 | ||||||||
|
Operating expenses: |
||||||||||
| Sales and marketing | 1,499,047 | 1,369,008 | ||||||||
| General and administrative expenses | 2,635,547 | 2,174,435 | ||||||||
| Depreciation | 91,583 | 91,224 | ||||||||
| Amortization of acquisition-related intangibles | 452,734 | 520,343 | ||||||||
| Total operating expenses | 4,678,911 | 4,155,010 | ||||||||
| (Loss) income from operations | (533,459 | ) | 432,138 | |||||||
|
Other income (expense): |
||||||||||
| Other income | 19 | 19 | ||||||||
| Interest expense | (403,461 | ) | (412,334 | ) | ||||||
| Total other income (expense) | (403,442 | ) | (412,315 | ) | ||||||
| (Loss) Income before provision for income taxes | (936,901 | ) | 19,823 | |||||||
| Income tax benefit (expense) | 229,558 | (13,539 | ) | |||||||
| Net (loss) income | $ | (707,343 | ) | $ | 6,284 | |||||
| Net (loss) income per share: | ||||||||||
| Basic | $ | (0.07 | ) | $ | 0.00 | |||||
| Diluted | $ | (0.07 | ) | $ | 0.00 | |||||
| Number of weighted average shares outstanding: | ||||||||||
| Basic | 9,586,608 | 9,216,719 | ||||||||
| Diluted | 9,586,608 | 9,615,285 | ||||||||
| CYNERGISTEK, INC. AND SUBSIDIARIES | ||||||||||
| RECONCILIATION OF GAAP (LOSS) INCOME FROM OPERATIONS TO NON-GAAP ADJUSTED EBITDA | ||||||||||
| (UNAUDITED) | ||||||||||
| Three Months Ended March 31, | ||||||||||
| 2018 | 2017 | |||||||||
| GAAP (loss) income from operations | $ | (533,459 | ) | $ | 432,138 | |||||
| Adjustments: | ||||||||||
| Depreciation | 91,583 | 91,224 | ||||||||
| Amortization | 452,734 | 520,343 | ||||||||
| Onetime restructuring and legal fees | 735,183 | - | ||||||||
| Stock-based compensation | 188,262 | 24,659 | ||||||||
| Non-GAAP adjusted EBITDA | $ | 934,303 | $ | 1,068,364 | ||||||
| Non-GAAP adjusted EBITDA per share | ||||||||||
| Basic | $ | 0.10 | $ | 0.12 | ||||||
| Diluted | $ | 0.09 | $ | 0.11 | ||||||
| CYNERGISTEK, INC. AND SUBSIDIARIES | ||||||||||
| RECONCILIATION OF GAAP NET (LOSS) INCOME TO NON-GAAP ADJUSTED EARNINGS | ||||||||||
| (UNAUDITED) | ||||||||||
| Three Months Ended March 31, | ||||||||||
| 2018 | 2017 | |||||||||
| GAAP Net (loss) income | $ | (707,343 | ) | $ | 6,284 | |||||
| Adjustments: | ||||||||||
| Cash tax adjustment | (229,558 | ) | 1,908 | |||||||
| Other expense | (19 | ) | (19 | ) | ||||||
| Onetime restructuring and legal fees | 735,183 | - | ||||||||
| Depreciation | 91,583 | 91,224 | ||||||||
| Amortization | 452,734 | 520,343 | ||||||||
| Stock-based compensation | 188,262 | 24,659 | ||||||||
| Non-GAAP adjusted earnings | $ | 530,842 | $ | 644,399 | ||||||
| Non-GAAP adjusted earnings per share | ||||||||||
| Basic | $ | 0.06 | $ | 0.07 | ||||||
| Diluted | $ | 0.05 | $ | 0.07 | ||||||
Conference Call Information
Date: Monday, May 14
Time:
12 pm Eastern Time / 9 am Pacific Time
U.S.: 1-888-394-8218
International:
1-323-701-0225
Conference ID: 8561147
Webcast: http://public.viavid.com/index.php?id=129443
A replay of the call will be available from 3 pm ET on May 14, to 11:59 pm ET on May 21. To access the replay, please dial 1-844-512-2921 from the U.S. and 1-412-317-6671 from outside the U.S. The PIN is 8561147.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity and information management consulting firm dedicated to serving the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, compliance, and document output management goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been named in numerous research reports as one of the top firms that provider organizations turn to for privacy and security, and won the 2017 Best in KLAS award for Cyber Security Advisory Services.
Forward-Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as, “believes,” “expects,” “anticipates,” “may,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Some of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
